Exhibit 99.1

                              FOR IMMEDIATE RELEASE

      Balchem Completes Acquisition of Akzo Nobel's European-based Choline
          Chloride and Methylamines Businesses at Marano Ticino, Italy

New Hampton,  New York. May 1, 2007.  Balchem  Corporation  (NASDAQ:BCPC)  today
announced  the  completion  of its  acquisition  of the  European-based  choline
chloride and  methylamines  businesses of Akzo Nobel Chemicals  S.p.A. in Marano
Ticino. Balchem and Akzo Nobel originally announced this acquisition on April 2,
2007. This facility and business will be operated by Balchem Italia,  S.r.l. and
employs  approximately 75 people in Marano Ticino.  In addition,  a three person
sales force operating out of Balchem  Trading B.V. in the Netherlands  will have
primary  responsibility  for the marketing,  sales and  distribution  of certain
products  produced  at the  facility.  In 2006,  the Akzo  Nobel  Marano  Ticino
business had approximately $35 million dollars (U.S.) in sales.

Balchem is a worldwide  leader in the  production  and sales of various  choline
chloride products, which are nutritional additives to animal feed and human food
products.  Methylamines  are a primary  building  block for the  manufacture  of
choline products and have several other chemical applications.

Dino Rossi,  Balchem's  President,  CEO and Chairman added, "The closing of this
transaction  marks a  tremendous  step  forward in the  evolution  and growth of
Balchem.  This  acquisition  provides a direct  platform for Balchem to meet the
growing market needs of methylamines,  choline chloride and derivative  products
for customers via improved global sourcing,  regulatory  support,  marketing and
distribution capabilities."

For more  details  regarding  the  closing of this  transaction,  including  the
provisional  purchase price, see Balchem's Form 8-K filing to be submitted to US
Securities and Exchange Commission (www.sec.gov).

About Balchem
Balchem Corporation consists primarily of three business segments: ARC Specialty
Products,  Encapsulated/Nutritional  Products, and BCP Ingredients.  Through ARC
Specialty  Products,  Balchem provides  specialty-packaged  chemicals for use in
healthcare and other industries. The  Encapsulated/Nutritional  segment provides
proprietary   microencapsulation   solutions   to  an   expanding   variety   of
applications.  BCP Ingredients  manufactures  and supplies  choline chloride and
derivatives used primarily in the poultry and swine industries.

Forward Looking Statements
This  release  contains  forward-looking  statements,  which  reflect  Balchem's
expectation  or  belief   concerning   future  events  that  involve  risks  and
uncertainties.  Balchem can give no assurance that the expectations reflected in
forward  looking  statements  will prove correct and various factors could cause
results to differ  materially from Balchem's  expectations,  including risks and
factors  identified  in Balchem's  annual report on Form 10-K for the year ended
December 31, 2004. Forward-looking statements are qualified in their entirety by
the above cautionary statement. Balchem assumes no duty to update its outlook or
other forward-looking statements as of any future date.

Contact:   Frank Fitzpatrick, Chief Financial Officer
           Telephone:  845-326-5600
           e-mail:  bcpexec@balchemcorp.com